Dopamine News and Research

Latest Dopamine News and Research

Anhedonia: The hidden psychological toll of deep endometriosis

Nearly 30% of women with deep endometriosis experience reduced pleasure sensitivity (anhedonia), linked to chronic pelvic pain, highlighting overlooked psychological consequences of this condition.

6 Jan 2025

New insights into uncontrollable movements in Parkinson's disease patients

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's disease patients: uncontrollable movements that develop after years of treatment.

3 Jan 2025

Propranolol helps control Parkinson's tremors

The standard medication levodopa does not always work against tremors in Parkinson's disease, especially in stressful situations.

23 Dec 2024

Study reveals brain circuits and chemical messengers behind the regulation of meal initiation

When you are feeling hungry, the brain takes the necessary steps toward consuming a meal. Many of these steps are not well known, but a new study published in the journal Metabolism by researchers at Baylor College of Medicine and the University of Texas Health Science Center at Houston reveals brain circuits and chemical messengers that contribute to the regulation of meal initiation and food intake.

20 Dec 2024

Research reveals how the brain processes fundamental learning calculations and social interactions

In a comprehensive Genomic Press Interview, Dr. Munir Gunes Kutlu, Assistant Professor at Temple University's Center for Substance Abuse Research, unveils revolutionary findings about how our brains process fundamental learning calculations and social interactions.

17 Dec 2024

Study reveals dopamine's role in stress-induced cardiovascular responses

Under stress, animals change their behavior, such as through "fight or flight" or "freezing" response. Simultaneously, physiological responses essential for stress adaptation are triggered in the body.

16 Dec 2024

Exercise enhances memory for up to 24 hours, study finds

The short-term boost our brains get after we do exercise persists throughout the following day, suggests a new study led by UCL (University College London) researchers.

9 Dec 2024

Boosting endocannabinoids could reduce opioid addiction risk

Increasing the levels of chemicals naturally produced in the body called endocannabinoids may thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs' ability to relieve pain, according to Weill Cornell Medicine investigators working with researchers from The Center for Youth Mental Health at NewYork-Presbyterian.

2 Dec 2024

Dopamine and serotonin balance reward learning in opposing ways

If you've heard of two of the brain's chemical neurotransmitters, it's probably dopamine and serotonin. Never mind that glutamate and GABA do most of the work - it's the thrill of dopamine as the "pleasure chemical" and serotonin as tender mood-stabilizer that attract all the headlines.

25 Nov 2024

Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption

The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with mixed results from clinical trials.

19 Nov 2024

Parkinson's study reveals dopamine's unexpected link to tremor

Researchers from the Champalimaud Foundation shed light on the puzzling relationship between dopamine and rest tremor in Parkinson's disease, finding that preserved dopamine in certain brain regions may actually contribute to tremor symptoms, challenging common beliefs.

18 Nov 2024

GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, warranting further clinical investigation.

18 Nov 2024

Prenatal cannabis exposure linked to increased risk of opioid addiction later in life

With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.

14 Nov 2024

New insights into early Huntington's disease mechanisms

Researchers uncover a link between impaired glutathione–ascorbate metabolism and early dopamine increases in Huntington's disease, suggesting GSTO2 as a potential therapeutic target to manage motor dysfunction.

4 Nov 2024

Researchers develop the first polymer-based therapeutic for Huntington’s disease

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein clumps and enhancing neuronal survival.

4 Nov 2024

Low vitamin D associated with increased depression risk in pregnancy and after birth

Research indicates that low vitamin D levels may contribute to anxiety and depression in pregnant women, emphasizing the importance of adequate supplementation.

29 Oct 2024

Researchers discover key biochemical mechanism in Huntington's disease development

Researchers from the University of Oxford have identified a key biochemical mechanism relevant to the development of Huntington's Disease.

28 Oct 2024

New research explores how antimicrobial exposure affects Parkinson’s disease risk

Antibiotic exposure shows potential protective effects against Parkinson's, while antifungal use is linked to increased risk, indicating microbiome involvement.

28 Oct 2024

Study reveals hormone receptors' role in brain health and neuroprotection

In a comprehensive review published in the October 2024 issue of Genomic Psychiatry, researchers have unveiled crucial insights into how two types of hormone receptors collaborate to maintain brain health and potentially prevent neurodegenerative diseases.

24 Oct 2024

Differential gene expression linked to alcohol use disorder, offering new treatment possibilities

Researchers identified key gene expression differences in addiction-relevant brain regions that provide new insights into alcohol use disorder and potential therapeutic targets.

14 Oct 2024

Dopamine News and Research

Latest Dopamine News and Research

Anhedonia: The hidden psychological toll of deep endometriosis

New insights into uncontrollable movements in Parkinson's disease patients

Propranolol helps control Parkinson's tremors

Study reveals brain circuits and chemical messengers behind the regulation of meal initiation

Research reveals how the brain processes fundamental learning calculations and social interactions

Study reveals dopamine's role in stress-induced cardiovascular responses

Exercise enhances memory for up to 24 hours, study finds

Boosting endocannabinoids could reduce opioid addiction risk

Dopamine and serotonin balance reward learning in opposing ways

Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption

Parkinson's study reveals dopamine's unexpected link to tremor

GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder

Prenatal cannabis exposure linked to increased risk of opioid addiction later in life

New insights into early Huntington's disease mechanisms

Researchers develop the first polymer-based therapeutic for Huntington’s disease

Low vitamin D associated with increased depression risk in pregnancy and after birth

Researchers discover key biochemical mechanism in Huntington's disease development

New research explores how antimicrobial exposure affects Parkinson’s disease risk

Study reveals hormone receptors' role in brain health and neuroprotection

Differential gene expression linked to alcohol use disorder, offering new treatment possibilities

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Dopamine News and Research

Latest Dopamine News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in